Jim Simons’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-23,216
| Closed | -$132K | – | 3695 |
|
|
2025
Q3 | $132K | Buy |
+23,216
| New | +$119K | ﹤0.01% | 3219 |
|
|
2024
Q4 | – | Sell |
-58,656
| Closed | -$267K | – | 3874 |
|
|
2024
Q3 | $267K | Sell |
58,656
-162,344
| -73% | -$785K | ﹤0.01% | 3020 |
|
|
2024
Q2 | $961K | Sell |
221,000
-14,958
| -6% | -$65.7K | ﹤0.01% | 2344 |
|
|
2024
Q1 | $1.19M | Buy |
235,958
+194,058
| +463% | +$1.09M | ﹤0.01% | 2386 |
|
|
2023
Q4 | $263K | Buy |
+41,900
| New | +$240K | ﹤0.01% | 3037 |
|
|
2023
Q3 | – | Sell |
-55,886
| Closed | -$569K | – | 4050 |
|
|
2023
Q2 | $569K | Sell |
55,886
-125,100
| -69% | -$1.31M | ﹤0.01% | 2803 |
|
|
2023
Q1 | $1.64M | Sell |
180,986
-29,000
| -14% | -$212K | ﹤0.01% | 2145 |
|
|
2022
Q4 | $1.51M | Buy |
209,986
+29,700
| +16% | +$181K | ﹤0.01% | 2261 |
|
|
2022
Q3 | $1.18M | Sell |
180,286
-11,300
| -6% | -$60.4K | ﹤0.01% | 2396 |
|
|
2022
Q2 | $923K | Buy |
191,586
+5,500
| +3% | +$27.2K | ﹤0.01% | 2776 |
|
|
2022
Q1 | $1.06M | Sell |
186,086
-2,900
| -2% | -$14.2K | ﹤0.01% | 2688 |
|
|
2021
Q4 | $949K | Sell |
188,986
-4,600
| -2% | -$25.3K | ﹤0.01% | 2685 |
|
|
2021
Q3 | $1.29M | Sell |
193,586
-22,900
| -11% | -$137K | ﹤0.01% | 2410 |
|
|
2021
Q2 | $1.32M | Buy |
216,486
+25,100
| +13% | +$151K | ﹤0.01% | 2516 |
|
|
2021
Q1 | $1.27M | Sell |
191,386
-55,700
| -23% | -$382K | ﹤0.01% | 2499 |
|
|
2020
Q4 | $1.31M | Sell |
247,086
-50,993
| -17% | -$399K | ﹤0.01% | 2366 |
|
|
2020
Q3 | $2.22M | Sell |
298,079
-35,607
| -11% | -$278K | ﹤0.01% | 2068 |
|
|
2020
Q2 | $2.46M | Buy |
333,686
+141,200
| +73% | +$1.24M | ﹤0.01% | 2075 |
|
|
2020
Q1 | $1.42M | Buy |
192,486
+28,809
| +18% | +$209K | ﹤0.01% | 2240 |
|
|
2019
Q4 | $926K | Buy |
163,677
+51,546
| +46% | +$264K | ﹤0.01% | 2670 |
|
|
2019
Q3 | $658K | Buy |
112,131
+66,631
| +146% | +$376K | ﹤0.01% | 2764 |
|
|
2019
Q2 | $145K | Buy |
+45,500
| New | +$149K | ﹤0.01% | 3353 |
|
Jim Simons's SCPH Position: Q4 2025 in Review
Jim Simons sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 23,216 shares — an estimated $132K sold.
Jim Simons first reported a position in SCPH in Q2 2019 and held it in 22 quarters. The position peaked at $2.46M in Q2 2020. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.
- Jim Simons reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Jim Simons sold 23,216 scPharmaceuticals shares in Q4 2025, an estimated $132K.
- Jim Simons first reported a position in scPharmaceuticals in Q2 2019 and held it in 22 quarters.
- Jim Simons's scPharmaceuticals position peaked at $2.46M in Q2 2020.
- 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.
Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.